We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
-23.7%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.06B
AUM Growth
-$330M
Cap. Flow
-$1.75M
Cap. Flow %
-0.17%
Top 10 Hldgs %
100%
Holding
1
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
JUNO
Juno Therapeutics, Inc.
JUNO
+$1.75M

Sector Composition

Rank Sector Weight
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
$1.06B 100%
25,948,799
-40,000
-0.2% -$1.75M

Similar funds

Crestline Management's Q3 2015 Portfolio in Review

As of Q3 2015, Crestline Management held 1 position worth $1.06B, down 24% from $1.39B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2015: portfolio turnover was 0%. Crestline Management opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

  • Crestline Management's biggest Q3 2015 reduction was Juno Therapeutics, Inc., cutting an estimated $1.75M.
  • Crestline Management's ten largest holdings make up 100% of its $1.06B portfolio in Q3 2015.
  • Crestline Management opened 0 new positions and closed 0 in Q3 2015.
  • Crestline Management's portfolio value fell 24% quarter-over-quarter to $1.06B.

Based on Crestline Management's 13F filing for Q3 2015, filed 12 Nov 2015.